Send to

Choose Destination
Neuroscience. 2013;255:55-67. doi: 10.1016/j.neuroscience.2013.09.047. Epub 2013 Oct 1.

Localized infusions of the partial alpha 7 nicotinic receptor agonist SSR180711 evoke rapid and transient increases in prefrontal glutamate release.

Author information

Department of Psychology, The Ohio State University, Columbus, OH, United States.


The ability of local infusions of the alpha 7 nicotinic acetycholine receptor (α7 nAChR) partial agonist SSR180711 to evoke glutamate release in prefrontal cortex was determined in awake rats using a microelectrode array. Infusions of SSR180711 produced dose-dependent increases in glutamate levels. The lower dose (1.0μg in 0.4μL) evoked a rapid rise (∼1.0s) in glutamate (1.41±0.30μM above baseline). The higher dose (5.0μg) produced a similarly rapid, yet larger increase (3.51±0.36μM above baseline). After each dose, the glutamate signal was cleared to basal levels within 7-18s. SSR180711-evoked glutamate was mediated by the α7 nAChR as co-infusion of the selective α7 nAChR antagonist α-bungarotoxin (10.0μM)+SSR1808711 (5.0μg) reduced the effect of 5.0μg alone by 87% (2.62 vs. 0.35μM). Finally, the clearance of the SSR180711 (5.0μg)-evoked glutamate was bidirectionally affected by drugs that inhibited (threo-beta-benzyl-oxy-aspartate (TβOA), 100.0μM) or facilitated (ceftriaxalone, 200mg/kg, i.p.) excitatory amino acid transporters. TβOA slowed both the clearance (s) and rate of clearance (μM/s) by 10-fold, particularly at the mid-late stages of the return to baseline. Ceftriaxone reduced the magnitude of the SSR180711-evoked increase by 65%. These results demonstrate that pharmacological stimulation of α7 nAChRs within the prefrontal cortex is sufficient to evoke rapid yet transient increases in glutamate levels. Such increases may underlie the cognition-enhancing effects of the drug in animals; further justifying studies on the use of α7 nAChR-positive modulators in treating cognition-impairing disorders in humans.


(+)-5-methyl-10,11-dihydro-5H-dibenzo [a, d] cyclohepten-5,10-imine maleate; AA; ACh; ANOVA; BSA; CEF; DA; EAAT; Gluox; MEA; MK-801; PFC; SZ; T(x); Tc(x); TβOA; acetylcholine; alpha 7; analysis of variance; bovine serum albumin; ceftriaxone; cognition; dopamine (3-hydroxytyramine); excitatory amino acid transporter; glutamate; glutamate oxidase; l-ascorbic acid; m-PD; m-Phenylenediamine dihydrochloride; microelectrode array; nAChR; nicotinic acetycholine receptor; prefrontal cortex; rat; schizophrenia; the clearance rate during x time period; the time to clear x% of the signal from the maximum amplitude; threo-beta-benzyl-oxy-aspartate; α-bungarotoxin; α7; αBGT

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center